Presentation is loading. Please wait.

Presentation is loading. Please wait.

A Symposium on a new development of Proton Radiotherapy Nijmegen, September 17th, 2010 We want to contribute to optimal treatments for patients close to.

Similar presentations


Presentation on theme: "A Symposium on a new development of Proton Radiotherapy Nijmegen, September 17th, 2010 We want to contribute to optimal treatments for patients close to."— Presentation transcript:

1 A Symposium on a new development of Proton Radiotherapy Nijmegen, September 17th, 2010 We want to contribute to optimal treatments for patients close to their livings “Stand-alone Proton Units” : a modern technique, innovative and cost effective Jos J. Immerzeel, Radiation Oncologist, RISO

2 2 Introduction This presentation: Developments in the Netherlands CPAC and the initiative in Deventer Promises and Perils of the new development Aim of this conference Jos J. Immerzeel

3 3 Developments in the Netherlands 2008: three initiatives in NL: Groningen, UMCG: protoncenter nearby nuclear- physics-accelerator-research center Maastricht: Euregional cooperation (with GER/BE) Amsterdam (NKI)- Rotterdam (Erasmus Univ.)- Leiden (Univ.)- Delft (Techn. Univ): Holland PTC 2009: National Health Counsil: positive (conditional) standpoint 2009: CvZ (College for Health Insurances): report on development of protontherapy; indications 2010: Gouvernmental Decision expected Q4 Jos J. Immerzeel

4 4 Developments in the Netherlands Potential indications: 7000 # units needed: “Classic” Protoncenter: 3-4 units Is another initiative for proton therapy in East NL necessary? Jos J. Immerzeel “Standard” indications in NL: 250

5 5 CPAC and the initiative in Deventer 2007: Tomotherapy: DWA development --> CPAC CPAC searches >15 investors/shareholders: RISO? Three investment tranches, three milestones March 2008: Board of RISO informed: positive about the opportunity Juli 2008: Board decision: participate, but no public (RISO) risk-investments possible. Need to search for private investors. Jos J. Immerzeel  2006: new RISO building, also 2 Tomotherapy (IMRT) units; up to now unique in the NL…

6 6 CPAC and the initiative in Deventer (2) Establishment of DEVPRON BV Second and third tranche: after end of risk period private investment + loan RISO (public ) Milestone 2009: acceleration of protons in a subscale DWA Jos J. Immerzeel First tranche: own investment with funding party. Risk investment (private)

7 7 CPAC and the initiative in Deventer (3) Participation in DEVPRON BV by the director should be less than 5% Investments by RISO in DWA is only possible when risk towards a succesful development is deminished. After this: the loan of RISO to Devpron BV can be considered as downpayment/investment Once decided to buy a unit, Devpron BV would be taken over by RISO. Jos J. Immerzeel Standpoints of Board of RISO:

8 8 Investors : first rights to achieve treatment units Participation in CPAC Scientific Advisory Board Installation of Stearing group (Stakeholders) Prof. Jurgen Debus (Heidelberg Ion-beam Therapy centre): Advisor for RISO RISO: search for partners (University!) CPAC and the initiative in Deventer (4) Jos J. Immerzeel 2010: promising developments of DWA

9 9 Regional cooperation: Technical University Twente and radiotherapy centers National: Investigation for cooperation with other initiatives CPAC and the initiative in Deventer (5) Jos J. Immerzeel July 2010: Partnership with University of Nijmegen/ St. Radboud

10 10 Promises and Perils of the new development Lower costs regarding infrastructure Lower costs for personell No admixture with neutrons BUT: Dose distribution of Protons: to good! Imaging and dosimetry: extremely important DWA is still a concept….. Jos J. Immerzeel  Installation in existing radiation oncology centers (single vault units)

11 11 Aim of this conference To inform the audience about the DWA compact Proton Accelerator and the initiative of Deventer /Nijmegen: more than a concept? To convince stakeholders, decision-makers and collegues that this new development really is a chance To initiate cooperation with the other initiatives (UMCG, Holland PTC, Maastricht) Jos J. Immerzeel

12 12 Cooperation in the Netherlands: Jos J. Immerzeel

13 13 Programme, Speakers Jos J. Immerzeel IntroductionJ. Immerzeel Clinical experience of particle therapy in Heidelberg M. Münter Technical aspects of protontherapyJ. Schippers DWA developmentsR. Mackie Coffee, Tea Proton facilitiesJ.W. Leer The UMC St.Radboud-RISO collaborationA. Minken PaneldiscussionJ.W. Leer Farewell reception


Download ppt "A Symposium on a new development of Proton Radiotherapy Nijmegen, September 17th, 2010 We want to contribute to optimal treatments for patients close to."

Similar presentations


Ads by Google